A randomized controlled trial found that patients hospitalized for an acute exacerbation of chronic obstructive poulmonary disease (COPD) experienced reduced rates of treatment failure when adding ...

An extended course of low-dose azithromycin (multiple brands) may significantly reduce treatment failure in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (COPD) ...

The COVID-19 pandemic is still spreading around the world and affecting nearly 2.4 million people, with over 164,000 dead so far. With neither vaccine nor proven therapeutic drug being available so ...

Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. We conducted ...

Azithromycin has been suggested as a possible COVID treatment, but clinicians should be aware of the drug’s potential to cause heart problems when taken with commonly used medications, researchers ...

The National Institutes of Health (NIH) has started a clinical trial to evaluate whether a drug combination promoted by President Trump as a potential COVID-19 treatment is effective. The trial will ...